Rockefeller Capital Management L.P. Verastem, Inc. Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$1.06 - $2.1 $6,676 - $13,227	6,299 Added 67.54%	15,626 $22,000
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $260 - $406	127 Added 1.38%	9,327 $19,000
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $1,270 - $2,035	-500 Reduced 5.15%	9,200 $28,000
Q2 2021 Aug 10, 2021	BUY	$2.57 - $4.85 $9,509 - $17,945	3,700 Added 61.67%	9,700 $39,000
Q4 2020 Feb 12, 2021	SELL	$1.15 - $2.4 $2,300 - $4,800	-2,000 Reduced 25.0%	6,000 $12,000
Q2 2020 Aug 12, 2020	SELL	$1.69 - $4.2 $1,690 - $4,200	-1,000 Reduced 11.11%	8,000 $14,000
Q1 2020 May 12, 2020	BUY	$1.26 - $3.38 $5,040 - $13,520	4,000 Added 80.0%	9,000 $24,000
Q4 2019 Feb 07, 2020	BUY	$0.86 - $1.44 $860 - $1,440	1,000 Added 25.0%	5,000 $7,000
Q3 2019 Nov 12, 2019	BUY	$1.21 - $1.59 $4,840 - $6,360	4,000 New	4,000 $5,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.